Volatile ride for Acasti Pharma stock price on Friday moving between $1.15 and $1.30
(Updated on Dec 03, 2021)

The Acasti Pharma stock price fell by -9.30% on the last day (Friday, 3rd Dec 2021) from $1.29 to $1.17. During the day the stock fluctuated 13.04% from a day low at $1.15 to a day high of $1.30. The price has fallen in 6 of the last 10 days and is down by -16.43% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -569 thousand shares and in total, 531 thousand shares were bought and sold for approximately $620.85 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.72% during the next 3 months and, with a 90% probability hold a price between $0.66 and $0.94 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Acasti Pharma stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.32 and $1.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, October 20, 2021, and so far it has fallen -35.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.15 between high and low, or 13.04%. For the last week the stock has had a daily average volatility of 8.74%.

Acasti Pharma is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Acasti Pharma stock A Buy?

Acasti Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -7.869

Remember To Visit Our YouTube Channel